Login / Signup

Placebo control group in COVID-19 vaccine trials: context and timing matters.

Rafael Dal-Ré
Published in: European journal of clinical pharmacology (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • double blind
  • phase iii
  • randomized controlled trial
  • placebo controlled